Related Experiment Video
Updated: Jun 13, 2025

06:32
Author Spotlight: Automated Deep Brain Stimulation for Parkinson's Disease - Exploring the Possibilities and Challenges of Home Monitoring
Published on: July 14, 2023
1.2K
Linking clinical trial participants to their U.S. real-world data through tokenization: A practical guide
Michael J Eckrote1, Carrie M Nielson2, Mike Lu2
1HealthVerity, Philadelphia, PA, USA.
Contemporary Clinical Trials Communications
|September 16, 2024
Summary
Linking real-world data (RWD) with clinical trial data enhances drug development. This approach improves treatment understanding and trial generalizability by connecting fragmented health information while preserving patient privacy.
Area of Science:
- Health Informatics
- Clinical Trials
- Real-World Data Analytics
Background:
- Real-world data (RWD) offers insights into patient experiences and treatment effects beyond clinical trials.
- Electronic health record (EHR) data integration is common in trials but faces challenges due to data fragmentation.
- Linking disparate RWD sources and trial data is crucial for comprehensive evidence generation.
Purpose of the Study:
- To describe the applications of linking real-world data (RWD) with clinical trial data.
- To highlight the benefits of RWD linkage for clinical development and real-world decision-making.
- To address operational considerations for privacy-preserving RWD linkage in clinical research.
Main Methods:
- Utilizing tokenization for privacy-preserving linkage of RWD and clinical trial data.
- Employing privacy-preserving record linkage systems with accuracy and precision metrics.
- Implementing participant consent management and site-level training for RWD access.
Main Results:
- RWD linkage enhances the interpretability and generalizability of clinical trial results.
- It aids in addressing missing data and losses to follow-up in trials.
- Extends patient follow-up beyond trial completion and characterizes trial applicability to diverse populations.
Conclusions:
- Linking RWD to clinical trial data bridges evidence gaps and improves the generalizability of trial findings.
- Privacy-preserving linkage methods are essential for ethical and effective data integration.
- Operational readiness, including consent and training, is key for successful RWD linkage implementation in trials.
Related Concept Videos
Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
Issues And Trends In Healthcare Delivery System
5.6K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.6K
Blinding
2.4K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.4K
Randomized Experiments
6.8K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
6.8K

